Key points are not available for this paper at this time.
These results suggest that HuLuc63 eliminates myeloma cells, at least in part, via NK-mediated ADCC and shows the therapeutic potential of targeting CS1 with HuLuc63 for the treatment of multiple myeloma.
Building similarity graph...
Analyzing shared references across papers
Loading...
Eric D. Hsi
Roxanne Steinle
Balaji Balasa
Clinical Cancer Research
Cleveland Clinic
University of South Florida
Moffitt Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Hsi et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69dd61830644c7b49d40d47e — DOI: https://doi.org/10.1158/1078-0432.ccr-07-4246